605 related articles for article (PubMed ID: 28986384)
1. Mass spectrometry for fragment screening.
Chan DS; Whitehouse AJ; Coyne AG; Abell C
Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
[TBL] [Abstract][Full Text] [Related]
2. A three-stage biophysical screening cascade for fragment-based drug discovery.
Mashalidis EH; Śledź P; Lang S; Abell C
Nat Protoc; 2013 Nov; 8(11):2309-24. PubMed ID: 24157549
[TBL] [Abstract][Full Text] [Related]
3. Biophysical screening for the discovery of small-molecule ligands.
Ciulli A
Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based drug discovery and its application to challenging drug targets.
Price AJ; Howard S; Cons BD
Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
[TBL] [Abstract][Full Text] [Related]
5. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
[TBL] [Abstract][Full Text] [Related]
6. Experiences in fragment-based lead discovery.
Hubbard RE; Murray JB
Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
[TBL] [Abstract][Full Text] [Related]
7. NMR in structure-based drug design.
Carneiro MG; Ab E; Theisgen S; Siegal G
Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
[TBL] [Abstract][Full Text] [Related]
8. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
9. Counting on Fragment Based Drug Design Approach for Drug Discovery.
Kashyap A; Singh PK; Silakari O
Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
[TBL] [Abstract][Full Text] [Related]
10. HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.
Wu B; Zhang Z; Noberini R; Barile E; Giulianotti M; Pinilla C; Houghten RA; Pasquale EB; Pellecchia M
Chem Biol; 2013 Jan; 20(1):19-33. PubMed ID: 23352136
[TBL] [Abstract][Full Text] [Related]
11. Native Mass Spectrometry in Fragment-Based Drug Discovery.
Pedro L; Quinn RJ
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483215
[TBL] [Abstract][Full Text] [Related]
12. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
[TBL] [Abstract][Full Text] [Related]
13. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
14. Experimental free ligand conformations: a missing link in structure-based drug discovery.
Chiarparin E; Packer MJ; Wilson DM
Future Med Chem; 2019 Jan; 11(2):79-82. PubMed ID: 30648432
[No Abstract] [Full Text] [Related]
15. Hit-to-Lead: Hit Validation and Assessment.
Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
[TBL] [Abstract][Full Text] [Related]
16. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based lead discovery and design.
Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
[TBL] [Abstract][Full Text] [Related]
18. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
Silvestre HL; Blundell TL; Abell C; Ciulli A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12984-9. PubMed ID: 23872845
[TBL] [Abstract][Full Text] [Related]
19. Fragment screening using X-ray crystallography.
Davies TG; Tickle IJ
Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
[TBL] [Abstract][Full Text] [Related]
20. Fragment-Based Ligand Designing.
Katiyar SP; Malik V; Kumari A; Singh K; Sundar D
Methods Mol Biol; 2018; 1762():123-144. PubMed ID: 29594771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]